Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $2.33 billion. The enterprise value is $2.35 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 26, 2024, after market close.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 124.32 million shares outstanding. The number of shares has increased by 8.53% in one year.
| Current Share Class | 124.32M |
| Shares Outstanding | 124.32M |
| Shares Change (YoY) | +8.53% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 3.92% |
| Owned by Institutions (%) | 73.20% |
| Float | 110.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 109.98 |
| Forward PS | 16.26 |
| PB Ratio | 7.03 |
| P/TBV Ratio | 7.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 119.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.65, with a Debt / Equity ratio of 1.34.
| Current Ratio | 4.65 |
| Quick Ratio | 4.49 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.83 |
Financial Efficiency
Return on equity (ROE) is -151.84% and return on invested capital (ROIC) is -44.97%.
| Return on Equity (ROE) | -151.84% |
| Return on Assets (ROA) | -40.72% |
| Return on Capital (ROIC) | -44.97% |
| Revenue Per Employee | $37,425 |
| Profits Per Employee | -$1.03M |
| Employee Count | 525 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.32% in the last 52 weeks. The beta is 0.93, so ARWR's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -33.32% |
| 50-Day Moving Average | 19.96 |
| 200-Day Moving Average | 24.70 |
| Relative Strength Index (RSI) | 38.49 |
| Average Volume (20 Days) | 1,032,402 |
Short Selling Information
The latest short interest is 9.39 million, so 7.55% of the outstanding shares have been sold short.
| Short Interest | 9.39M |
| Short Previous Month | 9.33M |
| Short % of Shares Out | 7.55% |
| Short % of Float | 8.49% |
| Short Ratio (days to cover) | 9.41 |
Income Statement
In the last 12 months, ARWR had revenue of $19.65 million and -$538.64 million in losses. Loss per share was -$4.66.
| Revenue | 19.65M |
| Gross Profit | 19.65M |
| Operating Income | -547.21M |
| Pretax Income | -539.92M |
| Net Income | -538.64M |
| EBITDA | -529.78M |
| EBIT | -547.21M |
| Loss Per Share | -$4.66 |
Full Income StatementBalance Sheet
The company has $434.47 million in cash and $454.12 million in debt, giving a net cash position of -$19.65 million or -$0.16 per share.
| Cash & Cash Equivalents | 434.47M |
| Total Debt | 454.12M |
| Net Cash | -19.65M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 338.97M |
| Book Value Per Share | 2.66 |
| Working Capital | 353.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$351.56 million and capital expenditures -$181.09 million, giving a free cash flow of -$532.65 million.
| Operating Cash Flow | -351.56M |
| Capital Expenditures | -181.09M |
| Free Cash Flow | -532.65M |
| FCF Per Share | -$4.28 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -2,785.05% |
| Pretax Margin | -2,792.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,707.55% |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.53% |
| Shareholder Yield | -8.53% |
| Earnings Yield | -23.16% |
| FCF Yield | -22.90% |
Dividend DetailsAnalyst Forecast
The average price target for ARWR is $45.33, which is 142.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $45.33 |
| Price Target Difference | 142.28% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 34.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
ARWR has an Altman Z-Score of -0.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.24 |
| Piotroski F-Score | 1 |